Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1997 Jun;150(6):1997–2007.

Prognostic relevance of a novel proliferation marker, Ki-S11, for soft-tissue sarcoma. A multivariate study.

P Rudolph 1, U Kellner 1, A Chassevent 1, F Collin 1, F Bonichon 1, R Parwaresch 1, J M Coindre 1
PMCID: PMC1858330  PMID: 9176393

Abstract

In 132 soft-tissue sarcomas and 52 benign soft-tissue tumors, cellular proliferation was examined by immunohistochemistry using monoclonal antibodies Ki-S11 (Ki-67 antigen) and Ki-S1 (topoisomerase II alpha) and by flow cytometric analysis of the S-phase fraction (SPF). Malignant tumors were graded histologically according to the Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC) system. Patient age, sex, tumor location, histological type, and DNA ploidy were considered as additional prognostic variables. Consistent immunoreactivity was seen in approximately 95% of the cases, and determination of SPF was possible in approximately 60% Ki-S11 and Ki-S1 immunolabeling indices correlated in a linear manner. All proliferation parameters yielded significant differences between benign and malignant tumors. Ki-S11 and Ki-S1 immunoreactive scores also co-varied significantly with SPF, mitotic count, and histopathological grade. In univariate analysis, immunohistochemical proliferation indices, histopathological grade, mitotic count, and SPF were predictive of overall survival and the development of metastases. In multivariate analysis, immunolabeling scores of proliferation markers, grade, and SPF emerged as independent predictors of global survival and systemic progression. We conclude that the immunohistochemical assessment of proliferation, being more readily performable and more easily assessable than the equally relevant S phase fraction, may add appreciable information to the current prognostic models for soft-tissue sarcoma.

Full text

PDF
1997

Images in this article

2000Figure 1
on p.2000
2001Figure 2
on p.2001
2002Figure 3
on p.2002

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agarwal V., Greenebaum E., Wersto R., Koss L. G. DNA ploidy of spindle cell soft-tissue tumors and its relationship to histology and clinical outcome. Arch Pathol Lab Med. 1991 Jun;115(6):558–562. [PubMed] [Google Scholar]
  2. Alho A., Skjeldal S., Melvik J. E., Pettersen E. O., Larsen T. E. The clinical importance of DNA synthesis and aneuploidy in bone and soft tissue tumours. Anticancer Res. 1993 Nov-Dec;13(6B):2383–2387. [PubMed] [Google Scholar]
  3. Alvegard T. A., Berg N. O., Baldetorp B., Fernö M., Killander D., Ranstam J., Rydholm A., Akerman M. Cellular DNA content and prognosis of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience. J Clin Oncol. 1990 Mar;8(3):538–547. doi: 10.1200/JCO.1990.8.3.538. [DOI] [PubMed] [Google Scholar]
  4. Baak J. P. Mitosis counting in tumors. Hum Pathol. 1990 Jul;21(7):683–685. doi: 10.1016/0046-8177(90)90026-2. [DOI] [PubMed] [Google Scholar]
  5. Bauer H. C., Kreicbergs A., Tribukait B. DNA content prognostic in soft tissue sarcoma. 102 patients followed for 1-10 years. Acta Orthop Scand. 1991 Jun;62(3):187–194. doi: 10.3109/17453679108993591. [DOI] [PubMed] [Google Scholar]
  6. Becker R. L., Jr, Venzon D., Lack E. E., Mikel U. V., Weiss S. W., O'Leary T. J. Cytometry and morphometry of malignant fibrous histiocytoma of the extremities. Prediction of metastasis and mortality. Am J Surg Pathol. 1991 Oct;15(10):957–964. doi: 10.1097/00000478-199110000-00006. [DOI] [PubMed] [Google Scholar]
  7. Camplejohn R. S., Brock A., Barnes D. M., Gillett C., Raikundalia B., Kreipe H., Parwaresch M. R. Ki-S1, a novel proliferative marker: flow cytometric assessment of staining in human breast carcinoma cells. Br J Cancer. 1993 Apr;67(4):657–662. doi: 10.1038/bjc.1993.122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Choong P. F., Akerman M., Willén H., Andersson C., Gustafson P., Baldetorp B., Fernö M., Alvegård T., Rydholm A. Prognostic value of Ki-67 expression in 182 soft tissue sarcomas. Proliferation--a marker of metastasis? APMIS. 1994 Dec;102(12):915–924. doi: 10.1111/j.1699-0463.1994.tb05253.x. [DOI] [PubMed] [Google Scholar]
  9. Coindre J. M., Terrier P., Bui N. B., Bonichon F., Collin F., Le Doussal V., Mandard A. M., Vilain M. O., Jacquemier J., Duplay H. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol. 1996 Mar;14(3):869–877. doi: 10.1200/JCO.1996.14.3.869. [DOI] [PubMed] [Google Scholar]
  10. Coindre J. M., Trojani M., Contesso G., David M., Rouesse J., Bui N. B., Bodaert A., De Mascarel I., De Mascarel A., Goussot J. F. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer. 1986 Jul 15;58(2):306–309. doi: 10.1002/1097-0142(19860715)58:2<306::aid-cncr2820580216>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  11. Costa J., Wesley R. A., Glatstein E., Rosenberg S. A. The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases. Cancer. 1984 Feb 1;53(3):530–541. doi: 10.1002/1097-0142(19840201)53:3<530::aid-cncr2820530327>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  12. Donhuijsen K. Mitosis counts: reproducibility and significance in grading of malignancy. Hum Pathol. 1986 Nov;17(11):1122–1125. doi: 10.1016/s0046-8177(86)80417-8. [DOI] [PubMed] [Google Scholar]
  13. Donhuijsen K., Schmidt U., Hirche H., van Beuningen D., Budach V. Changes in mitotic rate and cell cycle fractions caused by delayed fixation. Hum Pathol. 1990 Jul;21(7):709–714. doi: 10.1016/0046-8177(90)90030-9. [DOI] [PubMed] [Google Scholar]
  14. Dreinhöfer K. E., Akerman M., Willén H., Anderson C., Gustafson P., Rydholm A. Proliferating cell nuclear antigen (PCNA) in high-grade malignant fibrous histiocytoma: prognostic value in 48 patients. Int J Cancer. 1994 Nov 1;59(3):379–382. doi: 10.1002/ijc.2910590315. [DOI] [PubMed] [Google Scholar]
  15. Drobnjak M., Latres E., Pollack D., Karpeh M., Dudas M., Woodruff J. M., Brennan M. F., Cordon-Cardo C. Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarcomas. J Natl Cancer Inst. 1994 Apr 6;86(7):549–554. doi: 10.1093/jnci/86.7.549. [DOI] [PubMed] [Google Scholar]
  16. Gaynor J. J., Tan C. C., Casper E. S., Collin C. F., Friedrich C., Shiu M., Hajdu S. I., Brennan M. F. Refinement of clinicopathologic staging for localized soft tissue sarcoma of the extremity: a study of 423 adults. J Clin Oncol. 1992 Aug;10(8):1317–1329. doi: 10.1200/JCO.1992.10.8.1317. [DOI] [PubMed] [Google Scholar]
  17. Gerdes J., Lemke H., Baisch H., Wacker H. H., Schwab U., Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984 Oct;133(4):1710–1715. [PubMed] [Google Scholar]
  18. Gerdes J., Li L., Schlueter C., Duchrow M., Wohlenberg C., Gerlach C., Stahmer I., Kloth S., Brandt E., Flad H. D. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol. 1991 Apr;138(4):867–873. [PMC free article] [PubMed] [Google Scholar]
  19. Guillou L., Coindre J. M., Bonichon F., Nguyen B. B., Terrier P., Collin F., Vilain M. O., Mandard A. M., Le Doussal V., Leroux A. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol. 1997 Jan;15(1):350–362. doi: 10.1200/JCO.1997.15.1.350. [DOI] [PubMed] [Google Scholar]
  20. Gustafson P., Rydholm A., Willén H., Baldetorp B., Fernö M., Akerman M. Liposarcoma: a population-based epidemiologic and prognostic study of features of 43 patients, including tumor DNA content. Int J Cancer. 1993 Oct 21;55(4):541–546. doi: 10.1002/ijc.2910550404. [DOI] [PubMed] [Google Scholar]
  21. Gustafson P., Willén H., Baldetorp B., Fernö M., Akerman M., Rydholm A. Soft tissue leiomyosarcoma. A population-based epidemiologic and prognostic study of 48 patients, including cellular DNA content. Cancer. 1992 Jul 1;70(1):114–119. doi: 10.1002/1097-0142(19920701)70:1<114::aid-cncr2820700119>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  22. Hashimoto H., Daimaru Y., Takeshita S., Tsuneyoshi M., Enjoji M. Prognostic significance of histologic parameters of soft tissue sarcomas. Cancer. 1992 Dec 15;70(12):2816–2822. doi: 10.1002/1097-0142(19921215)70:12<2816::aid-cncr2820701215>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  23. Huuhtanen R. L., Blomqvist C. P., Wiklund T. A., Virolainen M. J., Elomaa A. I., Pan Y., Tribukait B. S-phase fraction of 155 soft tissue sarcomas: correlation with clinical outcome. Cancer. 1996 May 1;77(9):1815–1822. doi: 10.1002/(SICI)1097-0142(19960501)77:9<1815::AID-CNCR9>3.0.CO;2-A. [DOI] [PubMed] [Google Scholar]
  24. Jensen O. M., Høgh J., Ostgaard S. E., Nordentoft A. M., Sneppen O. Histopathological grading of soft tissue tumours. Prognostic significance in a prospective study of 278 consecutive cases. J Pathol. 1991 Jan;163(1):19–24. doi: 10.1002/path.1711630105. [DOI] [PubMed] [Google Scholar]
  25. Kraus D. H., Dubner S., Harrison L. B., Strong E. W., Hajdu S. I., Kher U., Begg C., Brennan M. F. Prognostic factors for recurrence and survival in head and neck soft tissue sarcomas. Cancer. 1994 Jul 15;74(2):697–702. doi: 10.1002/1097-0142(19940715)74:2<697::aid-cncr2820740224>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  26. Kreipe H., Alm P., Olsson H., Hauberg M., Fischer L., Parwaresch R. Prognostic significance of a formalin-resistant nuclear proliferation antigen in mammary carcinomas as determined by the monoclonal antibody Ki-S1. Am J Pathol. 1993 Feb;142(2):651–657. [PMC free article] [PubMed] [Google Scholar]
  27. Kroese M. C., Rutgers D. H., Wils I. S., Van Unnik J. A., Roholl P. J. The relevance of the DNA index and proliferation rate in the grading of benign and malignant soft tissue tumors. Cancer. 1990 Apr 15;65(8):1782–1788. doi: 10.1002/1097-0142(19900415)65:8<1782::aid-cncr2820650819>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  28. Leong A. S., Vinyuvat S., Suthipintawong C., Milios J. A comparative study of cell proliferation markers in breast carcinomas. Clin Mol Pathol. 1995 Apr;48(2):M83–M87. doi: 10.1136/mp.48.2.m83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Liu L. F. DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem. 1989;58:351–375. doi: 10.1146/annurev.bi.58.070189.002031. [DOI] [PubMed] [Google Scholar]
  30. Lopez F., Belloc F., Lacombe F., Dumain P., Reiffers J., Bernard P., Boisseau M. R. The labelling of proliferating cells by Ki67 and MIB-1 antibodies depends on the binding of a nuclear protein to the DNA. Exp Cell Res. 1994 Feb;210(2):145–153. doi: 10.1006/excr.1994.1022. [DOI] [PubMed] [Google Scholar]
  31. Mandard A. M., Petiot J. F., Marnay J., Mandard J. C., Chasle J., de Ranieri E., Dupin P., Herlin P., de Ranieri J., Tanguy A. Prognostic factors in soft tissue sarcomas. A multivariate analysis of 109 cases. Cancer. 1989 Apr 1;63(7):1437–1451. doi: 10.1002/1097-0142(19890401)63:7<1437::aid-cncr2820630735>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  32. Markhede G., Angervall L., Stener B. A multivariate analysis of the prognosis after surgical treatment of malignant soft-tissue tumors. Cancer. 1982 Apr 15;49(8):1721–1733. doi: 10.1002/1097-0142(19820415)49:8<1721::aid-cncr2820490832>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  33. Rudolph P., Lappe T., Hero B., Berthold F., Parwaresch R., Harms D., Schmidt D. Prognostic significance of the proliferative activity in neuroblastoma. Am J Pathol. 1997 Jan;150(1):133–145. [PMC free article] [PubMed] [Google Scholar]
  34. Rudolph P., Lappe T., Schubert C., Schmidt D., Parwaresch R. M., Christophers E. Diagnostic assessment of two novel proliferation-specific antigens in benign and malignant melanocytic lesions. Am J Pathol. 1995 Dec;147(6):1615–1625. [PMC free article] [PubMed] [Google Scholar]
  35. Russell W. O., Cohen J., Enzinger F., Hajdu S. I., Heise H., Martin R. G., Meissner W., Miller W. T., Schmitz R. L., Suit H. D. A clinical and pathological staging system for soft tissue sarcomas. Cancer. 1977 Oct;40(4):1562–1570. doi: 10.1002/1097-0142(197710)40:4<1562::aid-cncr2820400428>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  36. Schlüter C., Duchrow M., Wohlenberg C., Becker M. H., Key G., Flad H. D., Gerdes J. The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol. 1993 Nov;123(3):513–522. doi: 10.1083/jcb.123.3.513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Singer S., Corson J. M., Gonin R., Labow B., Eberlein T. J. Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma. Ann Surg. 1994 Feb;219(2):165–173. doi: 10.1097/00000658-199402000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Tanabe K. K., Pollock R. E., Ellis L. M., Murphy A., Sherman N., Romsdahl M. M. Influence of surgical margins on outcome in patients with preoperatively irradiated extremity soft tissue sarcomas. Cancer. 1994 Mar 15;73(6):1652–1659. doi: 10.1002/1097-0142(19940315)73:6<1652::aid-cncr2820730617>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  39. Tomita Y., Aozasa K., Myoui A., Kuratsu S., Uchida A., Ono K., Matsumoto K. Histologic grading in soft-tissue sarcomas. An analysis of 194 cases including AgNOR count and mast-cell count. Int J Cancer. 1993 May 8;54(2):194–199. doi: 10.1002/ijc.2910540206. [DOI] [PubMed] [Google Scholar]
  40. Trojani M., Contesso G., Coindre J. M., Rouesse J., Bui N. B., de Mascarel A., Goussot J. F., David M., Bonichon F., Lagarde C. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer. 1984 Jan 15;33(1):37–42. doi: 10.1002/ijc.2910330108. [DOI] [PubMed] [Google Scholar]
  41. Tsushima K., Rainwater L. M., Goellner J. R., van Heerden J. A., Lieber M. M. Leiomyosarcomas and benign smooth muscle tumors of the stomach: nuclear DNA patterns studied by flow cytometry. Mayo Clin Proc. 1987 Apr;62(4):275–280. doi: 10.1016/s0025-6196(12)61904-1. [DOI] [PubMed] [Google Scholar]
  42. Ueda T., Aozasa K., Tsujimoto M., Hamada H., Hayashi H., Ono K., Matsumoto K. Multivariate analysis for clinical prognostic factors in 163 patients with soft tissue sarcoma. Cancer. 1988 Oct 1;62(7):1444–1450. doi: 10.1002/1097-0142(19881001)62:7<1444::aid-cncr2820620733>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  43. Ueda T., Aozasa K., Tsujimoto M., Ohsawa M., Uchida A., Aoki Y., Ono K., Matsumoto K. Prognostic significance of Ki-67 reactivity in soft tissue sarcomas. Cancer. 1989 Apr 15;63(8):1607–1611. doi: 10.1002/1097-0142(19890415)63:8<1607::aid-cncr2820630827>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  44. el-Jabbour J. N., Akhtar S. S., Kerr G. R., McLaren K. M., Smyth J. F., Rodger A., Leonard R. C. Prognostic factors for survival in soft tissue sarcoma. Br J Cancer. 1990 Nov;62(5):857–861. doi: 10.1038/bjc.1990.394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. el-Naggar A. K., Ordóez N. G., Sara A., McLemore D., Batsakis J. G. Clear cell sarcomas and metastatic soft tissue melanomas. A flow cytometric comparison and prognostic implications. Cancer. 1991 Apr 15;67(8):2173–2179. doi: 10.1002/1097-0142(19910415)67:8<2173::aid-cncr2820670828>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  46. van Unnik J. A., Coindre J. M., Contesso C., Albus-Lutter C. E., Schiodt T., Sylvester R., Thomas D., Bramwell V., Mouridsen H. T. Grading of soft tissue sarcomas: experience of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer. 1993;29A(15):2089–2093. doi: 10.1016/0959-8049(93)90039-i. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES